tiprankstipranks
Trending News
More News >

Pharma Mar SA Updates on Share Buy-Back Program

Story Highlights
Pharma Mar SA Updates on Share Buy-Back Program

Confident Investing Starts Here:

The latest announcement is out from Pharma Mar SA ( (ES:PHM) ).

Pharma Mar SA has reported on its recent share buy-back program activities conducted between May 12 and May 16, 2025. This initiative is part of the company’s strategy to stabilize its stock and potentially enhance shareholder value, reflecting a proactive approach to managing its market presence.

The most recent analyst rating on (ES:PHM) stock is a Buy with a EUR108.00 price target. To see the full list of analyst forecasts on Pharma Mar SA stock, see the ES:PHM Stock Forecast page.

More about Pharma Mar SA

Pharma Mar SA operates in the pharmaceutical industry, focusing on the development and commercialization of marine-derived drugs. The company is known for its work in oncology and has a significant presence in the global market for cancer treatments.

YTD Price Performance: -1.63%

Average Trading Volume: 59,625

Technical Sentiment Signal: Buy

Current Market Cap: €1.41B

For detailed information about PHM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App